21 results
Thumbnail

D2.475 - Treatment delay and likelihood of remission on omalizumab in chronic spontaneous urticaria: a real-world observational study

Thumbnail

D2.465 - Omalizumab Enhances Safety and Supports Completion of Oral Immunotherapy in High-Risk Patients

Thumbnail

D2.466 - More options for the treatment of Chronic Spontaneous Urticaria: Tezepelumab

Thumbnail

D2.467 - Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a novel case

Thumbnail

D2.468 - Real-world effectiveness and safety of dupilumab in pediatric atopic dermatitis: a retrospective cohort study

Thumbnail

D2.469 - Pre-switch perceptions of omalizumab biosimilar prefilled pen in pediatric allergy: a cross-sectional survey

Thumbnail

D2.472 - Immunology Innovation Program: Developing Antibodies Against Novel Targets Through Co-creation

Thumbnail

D2.474 - Use of Dupilumab as treatment for Eosinophilic Enteritis: a case report

Thumbnail

D2.476 - Mepolizumab Enables Meaningful Real-World Improvements in SNOT-22 and Smell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Post Hoc Analysis of REALITI-N at 3 and 6 Months

Thumbnail

D3.370 - Three cases of erdosteine-induced delayed drug hypersensitivity

Thumbnail

D3.373 - Non-immediate Hypersensitivity Reactions To Both Penicillin and Aminopenicillin and Diagnostic approach – A Real Life Retrospective Study

Thumbnail

D3.372 - Rapid Intramuscular Penicillin Desensitization: A Promising Future

Thumbnail

D3.374 - Recall urticaria to dalteparin sodium in a patient with previous systemic reaction to nadroparin calcium

Thumbnail

D3.375 - Delayed-Type Drug Reactions in Pediatric Patients: Clinical Features and Management

Thumbnail

D3.376 - Drug Allergy Related to Chemotherapy and Premedication: Anaphylaxis Induced by Carboplatin and Methylprednisolone

Thumbnail

D3.378 - Drug hypersensitivity in children in a frontline setting: interim results of a pilot epidemiological project

Thumbnail

D3.380 - The Most Serious Threat in Perioperative Hypersensitivity Reactions (PHRs): Neuromuscular Blocking Agent (NMBA) Hypersensitivity and Cisatracurium as a Safe Haven in the Setting of Cross-Reactivity

Thumbnail

D3.381 - The paradox of treatment: H1-antihistamines-induced urticaria in a patient with chronic spontaneous urticaria

Thumbnail

D3.382 - Safety and outcomes of penicillin desensitization during pregnancy: experience from a tertiary referral center

Thumbnail

D3.383 - Delayed T-cell–mediated hypersensitivity to dimethyl fumarate: clinical presentation and diagnostic considerations